Skip to Content

3230 WPI (Meloxicam 7.5 mg)

Pill with imprint 3230 WPI is Yellow, Round and has been identified as Meloxicam 7.5 mg. It is supplied by Watson Pharmaceuticals.

Meloxicam is used in the treatment of osteoarthritis; inflammatory conditions; rheumatoid arthritis; fibromyalgia; tendonitis (and more), and belongs to the drug class Nonsteroidal anti-inflammatory drugs. Prior to 30 weeks gestation: Risk cannot be ruled out during pregnancy. Starting at 30 weeks gestation: There is positive evidence of human fetal risk during pregnancy. Meloxicam 7.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 3230 WPI

Meloxicam

Imprint:
3230 WPI
Strength:
7.5 mg
Color:
Yellow
Size:
8.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Nonsteroidal anti-inflammatory drugs
Pregnancy Category:
C - Risk cannot be ruled out - prior to 30 weeks gestation
D - Positive evidence of risk - starting at 30 weeks gestation
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Watson Pharmaceuticals
Inactive Ingredients:
lactose anhydrous
silicon dioxide colloidal
magnesium stearate
microcrystalline cellulose
pregelatinized starch
corn starch
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide